Monash receives largest share of federal medical research funding

Health Industry Hub | December 9, 2019 |
[Total: 1    Average: 4/5]

Monash University has been awarded more than $76 million in the latest round of National Health and Medical Research Council (NHMRC) funding to conduct vital research.

Federal Health Minister, the Hon. Greg Hunt, today announced over $400 million supporting more than 400 health and medical research projects through the NHMRC.

Monash was awarded more funding than any other Australian university.

The announcement also brings the total funding awarded to Monash for NHMRC and Medical Research Future Fund (MRFF) grants to more than $148.2 million in 2019 – an increase of $42 million on the previous year and the largest amount ever received in a single year.

Monash attracted funding across six of the seven NHMRC schemes – Ideas Grants (49), Postgraduate Scholarships (8), Clinical Trials and Cohort Studies Grants (5), Synergy Grants (3), Partnerships Grants (1), Targeted Calls for Research (1).

The funding will support a diverse range of projects from developing new antimalarial drugs, trials to reduce methamphetamine use and developing an integrated approach to precision medicine targeting antimicrobial resistance of bacterial ‘superbugs’.

The grants will be announced by Mr Hunt during a visit to Monash University today, where he will view the work of grant recipient Professor Tony Tiganis, from the Monash Biomedicine Discovery Institute (BDI).

Professor Tiganis was awarded a $1.7 million Ideas Grant to develop next generation therapies for cancer.

He said immune-based therapies are revolutionising the treatment of previously untreatable cancers. His project, conducted in collaboration with Professor Nicholas Huntington at the Monash BDI the Peter MacCallum Cancer Centre, will use cutting-edge preclinical tumour models and innovative approaches to enhance CAR cell therapies in cancer.

“This project has the potential to be a game-changing discovery in the field of cancer immunotherapy, leading to the next-generation of CAR T therapies that should increase their effectiveness in approved diseases and broaden their therapeutic utility to additional diseases such as solid cancers,” Professor Tiganis said.

“We are extremely grateful to the NHMRC for continuing to fund this vital research.”

Associate Professor Janet Bray, in partnership with the Project for Better Health, received a $905,000 Partnerships Grant to improve cardiovascular awareness and response to symptoms in regions at highest risk of heart attacks.

Professor Susan Charman received a $5 million Synergy Grant for her research into the identification and development of new antimalarial drugs. Malaria infects over 200 million people and causes over 440,000 deaths each year. Resistance has now emerged to all current classes of antimalarial medicines, so there is an urgent need to discover new classes of antimalarial drugs that target novel pathways in order to avoid cross-resistance with current medicines.

President and Vice-Chancellor Professor Margaret Gardner AO said the increase in funding for medical and health research at Monash was a remarkable result and testament to the University’s talented and dedicated researchers.

“This funding is vital in our commitment to help solve some of the world’s biggest medical challenges and improve the health of local and international communities, and recognises Monash as a global leader in medical research,” Professor Gardner said.

“I thank the NHMRC and the Minister for their continued support in recognising the importance of progressing these world-class projects, which are being pursued by our talented scientists, and for sharing in our desire to make a difference.”

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Human Resources

Human Resource Management - MSD revealed as finalist in Australian HR Awards

MSD revealed as finalist in Australian HR Awards

Health Industry Hub | July 13, 2020 |

The Australian HR Awards celebrates the outstanding achievements of the country’s top Human Resources leaders, companies and teams. MSD reveals […]


News & Trends - Medical Technology

MedTech News - Radiologists report a significant drop in diagnostic imaging services during COVID-19

Radiologists report a significant drop in diagnostic imaging during COVID-19

Health Industry Hub | July 13, 2020 |

MedTech News: Clinical radiologists are concerned that patients are delaying their required imaging procedures and encourage people to continue their […]



Medical Pharma Biotech MedTech - First-of-its-kind liver cancer research

First-of-its-kind liver cancer research

Health Industry Hub | July 13, 2020 |

Medical News: Primary liver cancer patients will benefit from a new research project in Western Australia that will apply the […]


News & Trends - Biotechnology

Biotech News - Australian researchers' cancer vaccine shows early promise

Australian researchers’ cancer vaccine shows early promise

Health Industry Hub | July 13, 2020 |

Biotech News: Mater University of Queensland Researchers have achieved publication in the highly-ranked journal, Clinical and Translational Immunology detailing their […]